Viewing nowOmeprazole Magnesium Trihydrate 40 mg
Esomeprazole Magnesium Trihydrate 43.38mg
Tablet · Prescription medication
Vivozon Pharmaceutical Co., Ltd.

MFDS item code 201507072 · Approved 2015.10.08 · Insurance code 658202940
Treatment and prevention of gastric acid disorders (reflux, etc.), ulcers, Helicobacter pylori infection, and NSAID-induced gastrointestinal disorders
This medication is used for the treatment of gastroesophageal reflux disease and erosive reflux esophagitis, and is effective as long-term maintenance therapy to prevent recurrence in patients with esophagitis. Additionally, it is used as a combination therapy with antibiotics for the treatment and prevention of recurrence in patients with Helicobacter pylori positive duodenal ulcers and peptic ulcers. It also helps with the short-term treatment of upper gastrointestinal symptoms due to non-steroidal anti-inflammatory drugs (NSAIDs), and aids in the treatment and prevention of gastric ulcers and duodenal ulcers associated with NSAID use. It is utilized in the treatment of Zollinger-Ellison syndrome and the maintenance therapy to prevent rebleeding from gastric or duodenal ulcers after intravenous infusion, effectively improving gastrointestinal disorders.
This medicine should be swallowed with a liquid such as water. Do not chew or crush it. 1. Adults 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue treatment for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is needed. · Once symptoms have resolved, subsequent recurring symptoms may be controlled with 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed use to control recurring symptoms is not recommended for patients at high risk of gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2) Combination therapy with antibiotics for the eradication of Helicobacter pylori Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, heartburn) associated with nonsteroidal anti-inflammatory drug use (nonselective or selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is needed. Clinical trials lasting more than 4 weeks have not been conducted. 4) Patients requiring continuous nonsteroidal anti-inflammatory drug therapy - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should then be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses above 80 mg per day should be divided into two doses. 6) Maintenance therapy after initiation of prevention of rebleeding from gastric or duodenal ulcers by intravenous injection Administer 40 mg once daily for 4 weeks after initiation of prevention of rebleeding from gastric or duodenal ulcers by intravenous injection. 4. Renal impairment No dose adjustment is necessary. Use with caution because there is limited experience in patients with severe renal impairment. 5. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. 6. Elderly patients No dose adjustment is necessary.
2. Adolescents 12 years of age and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue treatment for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further medical evaluation is needed. · Once symptoms have resolved, subsequent recurring symptoms may be controlled with 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed use to control recurring symptoms is not recommended for patients at high risk of gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 3. Children under 12 years of age There is no experience with the administration of this medicine to children under 12 years of age.
This medication should not be used in certain patients. For example, patients who are allergic to this drug or any of its components, who have experienced hypersensitivity reactions, those with a history of allergic reactions to specific antibiotics, patients with a history of heart disease, and breastfeeding women should not take this medication. This drug can cause various side effects. Common gastrointestinal symptoms such as headache, abdominal pain, diarrhea, constipation, nausea, and vomiting may occur; and rarely, blood disorders, skin rashes, liver function abnormalities, or neurological symptoms may appear. Additionally, severe allergic reactions or severe skin reactions may rarely occur, so immediate consultation with a physician is required if symptoms appear. Regular check-ups are necessary if this medication is taken for a long time. Long-term use may increase the risk of hypomagnesemia or fractures, so it is advisable to periodically check magnesium levels in the blood and undergo bone density tests. This drug can interact with other medications, so it is essential to inform your doctor or pharmacist of any other medications you are currently taking. Caution is especially needed when taken with anticoagulants, antibiotics, antivirals, and anticonvulsants. If you are pregnant or breastfeeding, the safety of this medication has not been sufficiently confirmed; therefore, it is important to consult with healthcare professionals before taking it. In case of overdose, there is no specific antidote; hence, it is crucial to receive appropriate treatment according to the symptoms. Store this medication out of reach of children and do not transfer it to another container.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reactions, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headache, dizziness, dysesthesia, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distention, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized erythema multiforme, drug reaction with eosinophilia and systemic symptoms, fractures, arthralgia, myalgia, muscular weakness, nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reactions, back pain, chest pain, sternal pain, facial swelling, facial flushing, fatigue, influenza-like symptoms, generalized edema, leg edema, lethargy, pain, stiffness, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, thrombocytopenia, hyperbilirubinemia, abnormal liver function, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, polymyalgia rheumatica, loss of appetite, apathy, increased appetite, confusion, worsening depression, hypertonia, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorders, tremors, visual field defects, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, altered sense of smell, loss of taste, taste distortion, abnormal urination, albuminuria, cystitis, dysuria, fungal infection, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric fundic polyps, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture. The storage temperature should ideally be maintained between 1 degree and 30 degrees Celsius at room temperature. This will help maintain the medication's efficacy and ensure safe usage.
Pink film-coated round tablets
28 tablets/box [14 tablets/Alu-Alu X 2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Trihydrate 43.38mg
Tablet · Prescription medication
Vivozon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.